The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors
about
Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virusSuppression of coronavirus replication by cyclophilin inhibitorsCuring a viral infection by targeting the host: the example of cyclophilin inhibitorsRecent developments in antiviral agents against enterovirus 71 infectionNTCP and beyond: opening the door to unveil hepatitis B virus entryFunctional protein microarray as molecular decathlete: a versatile player in clinical proteomicsCoronaviruses and the human airway: a universal system for virus-host interaction studiesVirus-host interactomics: new insights and opportunities for antiviral drug discoveryCoronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation.Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activitiesImmunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Systems virology: host-directed approaches to viral pathogenesis and drug targeting.Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseMERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatmentCyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling.A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.Genomic and proteomic analysis of Schizaphis graminum reveals cyclophilin proteins are involved in the transmission of cereal yellow dwarf virusBioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection.Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression.RNA sequencing-based analysis of the spleen transcriptome following infectious bronchitis virus infection of chickens selected for different mannose-binding lectin serum concentrationsGenome-Wide Screen Reveals Valosin-Containing Protein Requirement for Coronavirus Exit from Endosomes.Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirusSevere acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesiclesp53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitorsHuman enterovirus 71 protein interaction network prompts antiviral drug repositioning.Cyclophilin involvement in the replication of hepatitis C virus and other viruses.Cyclophilins as modulators of viral replication.Antiviral drug discovery: broad-spectrum drugs from nature.Enhanced molecular dynamics sampling of drug target conformations.Host Factors in Coronavirus Replication.Proteomic analysis for Type I interferon antagonism of Japanese encephalitis virus NS5 protein.Cyclophilin inhibitors block arterivirus replication by interfering with viral RNA synthesis.Suppression of feline coronavirus replication in vitro by cyclosporin A.Evaluation of a Bead-Free Coimmunoprecipitation Technique for Identification of Virus-Host Protein Interactions Using High-Resolution Mass Spectrometry.Current landscape and future prospects of antiviral drugs derived from microbial products.Transgene expression in the genome of Middle East respiratory syndrome coronavirus based on a novel reverse genetics system utilizing Red-mediated recombination cloning.
P2860
Q21131361-5B359852-4F3B-4A56-9B92-DFE21A695CA1Q26825245-1FAFE3BC-8F3F-4564-835F-55EEA78CB7FDQ26828727-639B3BCD-2A51-469A-ADB0-2D61CC02F169Q26849627-831EF101-6116-493E-BCFD-EAB8F419479DQ26999712-A761879C-A93A-42CA-9B92-3DB9CCD924F7Q27025953-8E7ADDA1-6659-4675-BC83-870309456348Q28075580-32AEC271-7592-4353-A1AB-9105E2DC01BAQ28652236-AE75A2D4-4573-47D1-8DFD-697C79283304Q30577917-DD22DB48-3530-4713-9D23-21CA05B0A878Q31132161-95183DC6-A818-411B-8C60-8BD42CA50B37Q33418708-EC4E3D1A-94C7-4A16-8165-92D416E8F980Q33637578-C823FC33-9BEB-4876-96B8-C8CFB68494DBQ34058365-22E714F4-8B4C-4322-AEF0-FFCBD91A5222Q34297821-B9582517-0278-4E89-8287-C213984C741BQ34468689-1853CA0B-F05C-4460-BA21-B4E69212E974Q34650943-267A3462-696E-4227-A65C-985C94B769A4Q34693445-1308DDD2-C7BF-49F0-9E36-025B7D9FA0DCQ34712064-BAC5C331-BC72-4471-830A-266F5BB2331FQ34945388-FAD6DB4E-99E1-43DA-A130-B325512526D7Q34950103-BAED192F-C1E7-4863-B4BF-680BCB6EDD14Q35108069-B9226338-2073-4EDC-9F48-7C3FB640ADF5Q35648811-36BA9AF1-0D41-4A17-951E-2634AB0DBEE7Q35906616-92BD6214-8F18-40B5-AE2E-EA3271813E8AQ36208116-CD399F6E-E9EB-4DBC-B815-D36F69BA432BQ36872701-F000DE4E-9C9A-48E0-B538-05B112F108C1Q37105681-7E52BF5F-73E2-48FD-8458-6952D4C7A70BQ37258617-BFB4C019-1C57-4662-AAF8-76DBA4080D64Q37596746-C6B5B43D-885A-402C-AAA5-8985F566E767Q37654728-860FE2A7-CF9B-40D7-AC8C-143B1C14AF18Q38040256-B65644D7-AF64-4B13-B228-EDA737A1BD6DQ38121470-DBEE5D80-A3DE-46DD-99E6-ACD39E464779Q38260235-026F030F-08DE-408F-931C-3B1EA754DF68Q38583453-77924193-F4F2-443C-BDEC-A8A201DDDE93Q38667715-C3ED07A6-E4E5-4AA5-B7B6-3BA064DEB200Q39069277-AC9AE892-884A-46F5-843E-65C5894A951CQ39244702-9BBE50C6-E438-4AC7-92FA-DA09728DF7B7Q39356376-D79E389B-9DF2-40BD-8D45-41A2047F5C0BQ40091516-91CF519A-D4AC-4DF3-BFDA-1ED902798AFDQ41919714-4626F172-31A5-4041-825D-31CBF64CECF5Q41923032-3EAFF63A-FC44-4C7F-9C2F-7C0C5B557048
P2860
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@ast
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@en
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@nl
type
label
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@ast
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@en
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@nl
prefLabel
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@ast
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@en
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@nl
P2093
P2860
P50
P1433
P1476
The SARS-coronavirus-host inte ...... for pan-coronavirus inhibitors
@en
P2093
Albrecht von Brunn
Christel Schwegmann-Wessels
Daniela Niemeyer
Ekatarina von Dall'Armi
Frank Schwarz
Georg Herrler
Heinz-Jürgen Thiel
Imke Steffen
Javier Carbajo-Lozoya
Julia Schöpf
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002331
P50
P577
2011-10-27T00:00:00Z